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Background: Specific cognitive rehabilitation in multiple sclerosis (MS) resulted to be
effective compared to no treatment. So far the possible role of an aspecific psychological
intervention on cognition has not been investigated.
Objective:The aim of the SMICT RCT was to compare the efficacy of a specific cognitive
training with an aspecific psychological intervention in relapsing-remitting MS patients.
Methods: From a sample of 150 patients, with the same disability and immunomodula-
tory therapy, submitted to neuropsychological examination, 45 impaired in at least one test
were included and 41 randomized to have either a specific cognitive training for the impaired
function (22) or to an aspecific psychological intervention (19) for 4 months, starting after
baseline examination. Neuropsychological tests and functional scales were administered
at baseline and 1 year later.
Results: After 1 year, the mean number of pathological tests was significantly lower in the
specific treatment group, compared to the aspecific group. Memory and attention/speeded
information processing functions were mostly improved. Depression and quality of life
were not different between groups at follow up.
Conclusion: Our study demonstrates that an intensive and domain specific cognitive
approach results to be more effective than aspecific psychological intervention in patients
with MS.
Keywords: multiple sclerosis, cognitive rehabilitation, attention, executive functions memory, information process-
ing speed, multiple sclerosis cognitive rehabilitation
INTRODUCTION
Patients affected by multiple sclerosis (MS) often suffer from
impairments in several cognitive domains (1). The incidence of
depression has also been found to be higher in MS (2, 3). For
these reasons, MS patients are more prone to loss of employ-
ment, reduced social and working abilities, and worsened qual-
ity of life (4, 5). The effects of immunomodulatory drugs on
cognitive deterioration are not completely clarified (6). Indeed,
cognitive interventions are worth investigating, since the method-
ological biases of the initial reports have been overcame by recent
research, supporting the efficacy of cognitive training in MS.
The heterogeneity in disease severity, the undetermined type of
treatments and the inappropriateness of outcome measures were
the most common confounders (7–9). However, the rehabili-
tation of selected cognitive domains (e.g., attention, executive
functions, memory) has been found to improve trained func-
tion (10–14), with reported correlates of brain functional acti-
vations (15–19). Targeted treatments were compared with no
treatment (12, 20) or control treatments (14, 21); though a possi-
ble aspecific due to a simple taking care effect has never ruled out
so far.
The aim of the Sclerosi Multipla Intensive Cognitive Training
(SMICT) trial is to verify the efficacy of a specific (S) inten-
sive cognitive training for attention/speeded information pro-
cessing (AIP), executive functions (EF), and memory (M) com-
pared to an aspecific psychological intervention (A) – a placebo
www.frontiersin.org January 2015 | Volume 5 | Article 278 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mattioli et al. MS cognitive training: a RCT
“psychological treatment” – in improving relapsing-remitting MS
patients’ cognitive impairment over one year.
PATIENTS AND METHODS
Ten Italian MS Centers participated in the SMICT study, whose
coordinator Center was the Neuropsychology Unit of Brescia Hos-
pital, which was responsible for data collection in an accessible
Data base and interpretation of the results. The randomized clini-
cal trial was registered in the Spedali Civili of Brescia trial Register
(NP:560).
Randomization (according to a computer-generated list of ran-
dom number) and statistical analysis of data were carried out by
an independent center, from which all the Centers received the
patients’ number.
Patients diagnosed as affected with MS, according to Poser et al.
criteria (22) with a relapsing remitting course were included in the
study, after their signed informed consent was obtained. The study
was performed according to the Helsinki Declaration and after the
approval of the Ethical Committee (Comitato Etico Provinciale di
Brescia, January 2010). Patients’ enrollment started on June 2010
and ended 31 December 2011.
To participate in the study, patients needed to have been pre-
scribed interferon beta 1A 44 mcg three times/week no later than
6 months before, in order to have the most homogeneous drug reg-
imen in patients. This first line therapeutic regimen was chosen,
as it has been shown to be effective on several neuropsychological
measures (6)Patients were included only if impaired (age corrected
z-score≤1.5 SD to norms) in at least one of the following test of the
Italian version of the Rao’s Brief Repeatable Battery: Paced Audi-
tory Serial Addition Task (PASAT 2′′, PASAT 3′′), Simbol Digit
modality Test (SDMT), Spatial Recall Test (SPART) 10/36, and
Delayed Recall (SPART D), Selective Reminding Test Long-Term
storage (SRT LTS), Consistent Long-Term Retrieval (SRT CLTR),
Delayed Recall (SRT DR) (23), Controlled Oral Words Association
(COWA) with the Phoneme (P) and Category (C) modalities (12),
and Stroop test (24). Eleven test’s scores were obtained for each
evaluation plus three functional scale scores. Exclusion criteria
were dementia (excluded by means of anamnestic reports as well
as MMSE >24 in patients), previous or present psychiatric disor-
ders (requiring pharmacological treatment) and clinically evident
relapse in the previous 6 months.
To detect a reduction of 2 (SD= 1.5) in the number of patho-
logical tests after the specific treatment, which is in agreement with
our previous study, with a two-sided 5% significance level and a
power of 90%, a sample size of 14 patients per group was neces-
sary. Given an anticipated drop out of 30%, the total number of
patients for each group increases to 18 (25).
The disease duration, the disability in the Expanded Disabil-
ity Status Scale [EDSS, Kurtzke (26)], the relapse rate and steroid
consumption (grams of intra venous methylprednisolone) in the
previous year were registered.
The neuropsychological battery, the Modified Fatigue Impact
Scale [MFIS, Kos et al. (27)] and MSQoL (28) were administered
at baseline and after one year. Alternative forms of the neuropsy-
chological tests were used, in order to avoid test retest effects and
learning effects. As it was previously shown (12, 13) that immedi-
ate post training significant improvement in attention/executive
function tests due to specific training is obtained and persists
after 6 months, we decided to assess this persistence at 1 year.
After inclusion, patients were randomly assigned to S treatment
or A treatment, whose scheduled duration was 15 consecutive
weeks with a frequency of two 60’ sessions per week, to be started
in 2 weeks after baseline evaluation, according with standardized
procedures, by an expert neuropsychologist, different from the
evaluating one. An out patient regimen was used in all the centers;
it was considered a maximum of three lost sessions as a cut off to
be excluded from the study.
S treatment was administered according to the impaired neu-
ropsychological function: Plan a Day software of the Rehacom
(www.schuhfried.at) was used if a patient resulted impaired in EF
(that is if his/her poor score was in the Stroop test or in the COWA
P or COWA/C); Memory software of the same package was used
if the patient was impaired in either the SRT or SPART verbal or
spatial memory measures and the previously described (29)A/IP
training, if he/she resulted impaired in AIP domain (pathologi-
cal PASAT 2′′, PASAT 3′′, SDMT). If a patient was impaired in
more than one domain, all the single domain trainings were bal-
anced in the hourly session each time. Exercises complexity was
adapted each time to the severity of each single patient’s impair-
ment in the selected domain, with the aim that the exercise had to
be challenging in each treatment session.
PLAN A DAY
The Plan a Day procedure trains the patient’s ability to organize,
plan and develop solution strategies, employing realistic simu-
lations of a set of scheduled dates and duties to be organized
at specific places in a small city map. Times for planning and
schedules are registered for each patient at each session and only
improvement and acquisition of sufficient planning abilities for
fulfilling all the appointments required led to an improved level
in the following treatment session. Fifty four levels of increas-
ing complexity are available, in order to challenge any grade of
impairment. This was considered a strategic behavior acquisition.
For further description of the treatment, see Mattioli et al. (12).
MEMORY
Patients were asked to give answer to multiple choice or open ques-
tions about tales of increasing length, which were presented on the
PC, whose complexity was chosen on the basis of the patient’s
memory impairment. Ten levels of difficulty – also with interfer-
ing condition of two or three tales alternatively presented with
the other tales’ questions – were progressively presented to the
patients.
A/IP TRAINING
A specific speeded information training with increasing velocity
(from 4000 to 1800 ms interval), which has been shown to be
effective in patients with brain injuries, was used, consisting of a
modified PASAT task with numbers, words, and months of the
year, according to Serino et al. (29) procedure.
The A treatment was performed, independently of the single
tests’ impairment and was conducted by the psychologist by using
conversation about the patient’s disease perception, his/her work,
family, and hobbies, with the aim not to specifically exercise a cog-
nitive ability, avoiding to treat depression or to have any behavioral
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FIGURE 1 | Consort 2010 flow diagram.
or psychoanalytic approach. All the psychologists were trained by
attending 10 consecutive training meetings with the psychologists
of the coordinator center.
All the patients, after the neuropsychological examination at
1 year follow up, were considered as recovered, if the neuropsy-
chological examination was normal, or still impaired, if not.
STATISTICAL ANALYSIS
Descriptive statistics of quantitative variables are expressed as
median, 25th and 75th percentiles.
Due to low sample size in each group and to the not nor-
mally distributed variables under examination, the two groups
were compared using Mann–Whitney statistic test for quantitative
variables and Fisher Exact test for qualitative variables.
To assess the association between the difference in the number
of pathological tests and the type of treatment a multiple linear
regression model was fitted using the following covariates: EDSS
change, mFIS, MSQoL, MADRS, number of relapse in the previous
year, steroid consumption, sex, and age at T12.
All statistical analyses were performed using STATA/SE version
12.1 software (STATA/SE, 2011).
RESULTS
One hundred and fifty MS patients with the requested disease and
treatment characteristics were submitted to neuropsychological
evaluation, from April 2010 to December 2012. Of these, 109 were
excluded; 89 because of they did not have the requested neuropsy-
chological characteristics, 16 because they declined to participate
www.frontiersin.org January 2015 | Volume 5 | Article 278 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mattioli et al. MS cognitive training: a RCT
(mainly for organization problems due to work/household rea-
sons), and 45 were included. Four were not randomized to treat-
ments, due to early drop out (for difficulties in accessing the MS
Center in two cases and in maintaining the treatment due to work
in the other two cases).
Forty one patients were randomly assigned to treatment A
(19 patients) and treatment S (22 patients). Details are shown
in Figure 1.
Patients’ groups were not significantly different for age, years of
education, disease duration, relapse number in the previous year,
EDSS, steroid consumption in the previous year (Table 1), and
gender (males/females: 8/11 in group A and 9/13 in group S, n.s.
Pearson χ2 test).
Baseline neuropsychological evaluation did not show any sta-
tistically significant difference in the mean number of impaired
tests between the two groups (2.21± 1.18 in A and 2.91± 1.48
in S group; n.s. Mann–Whitney test), demonstrating a generally
moderate impairment in patients’cognition. In addition, the mean
raw score of tests at baseline was not significantly different between
groups, except for SRT DR, which was marginally significantly
lower in group S compared to group A. M Fis, MsQol, and MADRS
sores were not different at follow up (Table 2).
The number of rehabilitative sessions performed in the first
year, did not differ between groups (27.79± 5.48 in A and
26.32± 10.19 in S; n.s. Mann–Whitney test). In particular, S
treatments were distributed as follows (denominators are the
total number of patients assigned to S treatment): Memory in
16 cases (72%), Plan a Day in 11 (50%), and A/IP in 12 cases
(55%), confirming the well known data that memory is the most
frequently impaired cognitive domain in MS.
Table 1 | Characteristics of the study sample at baseline (T0).
Treatment A (n=19) Treatment S (n=22) p-Value*
25th % Median 75th % 25th % Median 75th %
Age (years) 34 43 53 38 45 50 0.74
Years of education 8 13 14 8 9.5 15 0.47
Disease duration (months) 12 36 96 12 23.5 120 0.49
Relapses (previous year) 1 1 2 0 1 2 0.96
EDSS 1 2 3.5 2 2 3 0.78
Steroid (gr) 0 5 7 0 5 6 0.47
*Mann–Whitney test.
A, aspecific; S, specific; EDSS, Expanded Disability Status Scale.
Table 2 | Comparison of raw scores of neuropsychological tests at baseline (T0) between the two groups.
Test Treatment A (n=19) Treatment S (n=22) p-Value*
25th % Median 75th % 25th % Median 75th %
PASAT3′′ 25 35 40 27 35 43 0.61
PASAT2′′ 18 23 32 20 24.2 30 0.86
SPART10/36 14 17 23 13 14.5 21 0.33
SPARTDR 4 6 7 3 5 7 0.33
SRTLTS 29 34 46 24 30 44 0.31
SRTCLTR 21 24 40 17 21 36 0.15
SRTDR 6 8 9 6 6.5 8 0.044
SDMT 28 39 47 33 44 50 0.33
COWAP 23 30 37 25 34.5 40 0.15
COWAC 32 41 48 31 43.5 51 0.93
Stroop 13 20 30 19 20 29 0.74
MSQoL 130 167 186 138 167 201 0.68
MADRS 4 7 17 3 8 14 0.81
mFIS 6 26 46 14 29.5 47 0.62
*Mann–Whitney test.
A, aspecific; S, specific; PASAT3′′, PASAT2′′, Paced Auditory Serial Addition Test; SPART10/36, 10/36 Spatial Recall Test for visuo-spatial learning – long-term retrieval;
SPARTDR, Spatial Recall Test for visuo-spatial learning – delayed recall; SRTLTS, Selective Reminding Test – Long-Term storage; SRTCLTR, Selective Reminding
Test – Consistent Long-Term Retrieval; SRTDR, Selective Reminding Test – delayed recall; SDMT, Symbol Digit Modalities Test; COWAP, Controlled Oral Words
Association – Phoneme; COWAC, Controlled Oral Words Association – Category.
Stroop: MSQoL, Multiple Sclerosis Quality of Life; MADRS, Montgomery–Asberg Depression Rating Scale; mFIS, Modified Fatigue Impact Scale002E.
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After rehabilitation, the mean number of impaired neuropsy-
chological tests was found to be significantly lower in group S
(3.53± 2.12 in A and 1.95± 2.97 in S; p< 0.01 Mann–Whitney
test), demonstrating that patients submitted to treatment S
improved after 1 year, whereas those ones submitted to the A
treatment worsened. Furthermore, at T12 we found a statistically
significant difference in the number of recovered patients; that is,
patients with completely normal neuropsychological examination
(1/19 for treatment A vs. 11/22 for treatment S, Pearson χ2 test
p= 0.002).
The advantage of group S was confirmed also by analyz-
ing the change (T12-T0) in the number of pathological tests
between groups, which revealed a significant improvement in S
(−0.95± 2.24) compared to A patients (1.32± 1.60, p= 0.0005
Mann–Whitney test).
Comparison of change (T12-T0) on raw score of neuropsy-
chological tests between groups showed a significantly higher
difference in group S for SRT DR and SPART 10/36 (Table 3), indi-
cating that memory is the cognitive domain that most significantly
changes after treatment S.
The within groups analysis of change (T12-T0) on raw scores in
neuropsychological tests shows that patients treated with S treat-
ment significantly improve in almost all the tests and in the fatigue
scale, whereas patients treated with A significantly improve in
PASAT 2′′ and PASAT 3′′ only (Table 4).
The multivariate regression analysis shows that the type of
treatment is significantly associated with the difference in the
number of impaired tests (p< 0.001). Specifically, patients treated
with the S treatment have on average 2 impaired tests less than
patients treated with A treatment, after adjusting for demographic,
clinical and quality of life parameters (gender, age at T12, EDSS,
number of relapses, steroid use, mFIS, MSQoL, and MADRS).
Both in A and in S group we could not find any significant change
in MSQoL, m Fis, and MADRS after 1 year.
Considering the specificity of the single S treatment (Plan a
Day, Attention/IP, and Memory) used for the function treated,
compared to the A approach, we also found a significantly higher
improvement in group S for memory tests (SRT DR, SPART 10/36)
and Attention/IP (SDMT), compared to group A (Table 5), show-
ing that S training is better than A, particularly in treating memory
and attention/IP functions, for which an increase ranging from
four to fivefold was observed in tests’ scores. No statistically sig-
nificant difference was found for executive function tests and Plan
a day training.
DISCUSSION
Based on previous research, we hypothesized that an interven-
tion with specific exercises for single patient’s neuropsychological
deficit would yield significantly larger cognitive benefits than aspe-
cific psychological care. We found that MS patients engaged in
a specific cognitive training significantly reduced the number of
impaired neuropsychological tests and in general improved in
tests’ scores. We observed no such improvements in the group
assigned to an aspecific training. Importantly, although PASAT
scores ameliorated after 1 year also in aspecific group – possibly
due to a general effect on attention, the changes in tests’ perfor-
mance after 1 year significantly favored the Specific group in 10
out of 11neuropsychological test. These differences and improve-
ments are significant not only between groups but also within
groups. Patients were well matched for both clinical and thera-
peutic characteristics, in order to ensure that the improvement
was attributable to the type of the cognitive training only; in
particular this trial is the first one, to our knowledge, in which
a specific cognitive treatment is compared to an aspecific psy-
chological intervention on relapsing-remitting MS patients all
prescribed with the same immunomodulatory drug from the same
time. Moreover, a multicenter study permits to replicate the same
rehabilitative procedure in different centers. The effect of domain
Table 3 | Comparison of changes in the neuropsychological tests raw scores at baseline (T0) and after rehabilitation (T12) between the two
groups.
Difference on raw scoresT12–T0 Treatment A (n=19) Treatment S (n=22) p-Value*
25th % Median 75th % 25th % Median 75th %
∆PASAT3 0 4 9 2 6 10 0.46
∆PASAT2 0 3 8 0 8 10 0.42
∆SPART10/36 −1 0 5 1 4 7 0.0395
∆SPARTDR −1 0 3 0 1 4 0.36
∆SRTLTS 0 6 17 4 10 16 0.34
∆SRTCLTR −4 4 12 2 7.5 16 0.22
∆SRTDR −1 0 1 1 1.5 3 0.0076
∆SDMT 0 1 5 1 3 7 0.24
∆COWAP −2 1 4 −1 3 8 0.36
∆COWAC −2 2 6 2 3.5 7 0.2
∆Stroop −1 2 5 −1 2 7 0.96
∆MSQoL 9 1 7 −12 0 9 0.98
∆MADRS −4 0 1 −3 −0.5 1 0.72
∆mFIS −9 −1 4 −8 −2.5 0 0.52
*Mann–Whitney test.
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Table 4 | Comparison of change in neuropsychological tests raw scores at baseline (T0) and after rehabilitation (T12) within the two groups.
Treatment A (n=19) p-Value* Treatment S (n=22) p-Value*
T0
Median
T12
Median
T0
Median
T12
Median
PASAT3 35 36 0.0014 35 44.5 0.002
PASAT2 23 30 0.0012 24.2 33.5 0.0070
SPART10/36 17 19 0.47 14.5 21.5 0.0008
SPARTDR 6 6 0.37 5 7 0.0352
SRTLTS 34 40 0.05 30 42 0.0004
SRTCLTR 24 28 0.13 21 31 0.0010
SRTDR 8 8 0.29 6.5 8 0.0007
SDMT 39 40 0.06 44 47.5 0.0004
COWAL 30 30 0.26 34.5 34.5 0.0456
COWAC 41 42 0.29 43.5 44.5 0.0260
Stroop 20 27 0.05 20 29 0.09
MSQoL 167 151 0.98 167 157.2 0.90
MADRS 7 8 0.81 8 6 0.23
mFIS 26 18 0.53 29.5 26 0.09
*Wilcoxon signed-rank test.
Table 5 | Comparison of change in Executive function, Attention and Memory domain neuropsychological tests (raw scoresT12-T0) within the A
group and the three S treatments.
Treatment A Treatment S p-Value*
25th % Median 75th % 25th % Median 75th %
Executive functions (19 vs. 11 patients)a Plan a day
∆COWA C −2 1 4 −1 7 14 0.32
∆COWA P −2 2 6 −7 3 5 0.88
∆Stroop −1 2 5 −1 1.5 10 0.84
Attention (19 vs. 12 patients)a Attention/IP
∆PASAT3 0 4 9 1 9.5 15 0.21
∆PASAT2 0 3 8 4 9 15 0.15
∆SDMT 0 1 5 2.5 6.5 9 0.0263
Memory (19 vs. 16 patients)a Memory
∆SPART10/36 −1 0 5 1 3.5 7.5 0.0394
∆SPARTDR −1 0 3 −0.5 1.5 4 0.31
∆SRTLTS 0 6 17 4.5 10 17.5 0.29
∆SRTCLTR −4 4 12 3 7.5 15 0.18
∆SRTDR −1 0 1 0.5 1 2.5 0.03
*Mann–Whitney test.
aNumber of patients of the S group submitted to the domain specific treatment vs. the patients of the A group submitted to the A treatment.
specific treatment is relevant, as at 1 year follow up, approximately
40% of patients submitted to the Specific treatment completely
recovered compared to only 5% of patients in the Aspecific group,
who, on the contrary, generally worsened. All the treated cognitive
areas improved after specific exercises. This confirms our previ-
ous results on attention/information processing (12, 13) and also
recent data from Chiaravalloti et al. (11) on memory.
Surprisingly, neither MSQoL nor MADRS (measures of quality
of life and depression) were improved by treatment A, showing
that an aspecific psychological intervention does not prove to be
useful both on MS cognitive and on mood disorders.
Considering the high frequency of cognitive deficits in MS
patients and their impact on patients’ activities, there is an urgent
need to establish therapeutic interventions able to significantly
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alleviate these deficits. Despite cognitive rehabilitation being
widely used in clinical practice, recent Cochrane revisions (9,
30) stated that, mainly due to methodological limitations of the
currently available studies and subjects’ heterogeneity, at present
there is a low level of evidence for the positive effects of neu-
ropsychological rehabilitation in MS. Rehabilitation of selected
cognitive domains (e.g., attention, EF, memory) has been associ-
ated with improved cognitive performance in the trained function
in patients with MS (11, 12, 16, 17, 19), although often the train-
ing group was matched with no treatment group. In our study,
a domain specific cognitive treatment was compared to an aspe-
cific psychological care also in attention/IP and executive function
deficits and the effects were found at 1 year. Our patients were
all treated with interferon beta 1A 44 mcg three times/week no
later than 6 months before randomization, the sample was well
matched, with a moderate cognitive impairment, consistent with
the disease type of the patients studied and other possibly induc-
ing cognitive improvement other than the training may be ruled
out. Furthermore, we can reasonably exclude that S patients could
have improved due to a practice effect and not to learning of new
strategies; in fact training procedures are very different from the
tests’ tasks. In addition, these were used in alternate forms.
In conclusion, data show that relatively short periods of domain
specific cognitive training can be helpful in ameliorating the
trained function with effects persisting at 1 year and are superior
to aspecific psychological interventions.
It is worth considering that the cognitive treatment was gen-
erally well tolerated and accepted, although in some centers, a
practical difficulty in carrying out the complete rehabilitation
program was observed: particularly a reduced compliance was
reported for those cases where the rehabilitation had to be per-
formed within the General Hospital, where most of the italian
MS Centers are located, and not in a separate and possibly more
easily accessible neuropsychological rehabilitation unit. Finally,
the duration of the program could have had a role in reduc-
ing the size of the sample in our study; a shorter, but equally
effective programs of cognitive rehabilitation could be more
useful (31).
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